OMID Holdings (OMID) AI Stock Analysis

• Market Cap: $1.50M
• Dividend Yield: N/A
• Average Volume (3M): 10.61K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.45
• Revenue Growth: 109.73%
• EPS Growth: -134.29%
• Country: US
• Employees: 6
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): >-0.01
• Shares Outstanding: 79,197,120
• 10 Day Avg. Volume: 12,157
• 30 Day Avg. Volume: 10,614
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 2.05
• Enterprise Value/Revenue: 12.47
• Enterprise Value/Gross Profit: -11.21
• Enterprise Value/Ebitda: -6.48
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 42 Neutral
• Price Target: ―

OMID Holdings is facing significant financial and operational challenges, reflected in poor financial performance and negative valuation metrics. Technical analysis indicates bearish momentum, and the absence of strong earnings call insights adds to the uncertainty. The overall score reflects these challenges, highlighting the need for improved operational efficiency and revenue growth.

OMID Holdings Business Overview & Revenue Model

Company Description

OMID Holdings, Inc., a health and wellness company, engages in the manufacture and sale of CBD-based products. The company is based in Phillipsburg, New Jersey.

How the Company Makes Money

OMID Holdings generates revenue primarily through the sale of its hemp and CBD-based products. These products are distributed through various retail and online channels, allowing the company to reach a broad consumer base. Key revenue streams include direct sales to consumers via the company's e-commerce platform and wholesale distribution partnerships with retailers. OMID may also engage in strategic collaborations with other companies in the industry to broaden its market reach and enhance product offerings. The company's earnings are influenced by factors such as consumer demand for wellness products, regulatory developments in the hemp and CBD industry, and the effectiveness of its marketing strategies.

OMID Holdings Financial Statement Overview

Summary

OMID Holdings faces financial challenges with declining revenues and profitability issues. Despite some improvement in gross profit margin and positive equity growth, high leverage and weak cash flow generation present significant risks.

Income Statement

OMID Holdings has faced significant revenue decline from 2021 to 2023, with a notable drop in profitability metrics. The gross profit margin has improved from negative to positive in 2023, indicating some recovery in cost management. However, the net profit margin remains weak despite a return to profitability in 2023, and EBIT continues to be negative, suggesting operational challenges.

Balance Sheet

The balance sheet shows a reasonable equity ratio, though it has declined over recent years, indicating a reduction in financial stability. The debt-to-equity ratio is relatively stable but slightly elevated, which could pose risks if profitability does not improve. The positive growth in stockholders' equity from 2022 to 2023 is a positive sign.

Cash Flow

OMID Holdings has struggled with negative free cash flow in recent years, significantly impacting its liquidity position. The operating cash flow remains negative, indicating ongoing challenges in generating cash from operations. There has been some reduction in capital expenditures, but overall cash flow health is concerning.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	247.59K	522.24K	1.55M	2.15M	1.33M
Gross Profit	-275.31K	60.21K	-87.82K	853.70K	637.61K
EBITDA	-476.25K	57.40K	-444.86K	559.95K	437.58K
Net Income	-850.59K	34.64K	-330.53K	484.05K	425.76K
Balance Sheet
Total Assets	828.01K	818.02K	912.49K	1.68M	577.65K
Cash, Cash Equivalents and Short-Term Investments	646.08K	137.82K	469.94K	931.38K	262.66K
Total Debt	333.97K	342.86K	339.57K	351.18K	86.10K
Total Liabilities	378.78K	402.44K	592.39K	1.04M	261.82K
Stockholders Equity	449.23K	415.58K	320.10K	639.40K	315.83K
Cash Flow
Free Cash Flow	-367.10K	-427.70K	-478.75K	307.50K	58.94K
Operating Cash Flow	-367.10K	-408.04K	-420.87K	341.07K	140.18K
Investing Cash Flow	-64.34K	-19.66K	-57.88K	-33.57K	-81.24K
Financing Cash Flow	563.04K	56.73K	68.42K	227.94K	200.60K

OMID Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OMID, the sentiment is Neutral. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.28 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for OMID.

OMID Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OMID	42 Neutral	$1.50M	―	-167.84%	―	109.73%	-134.29%
MJNA	39 Underperform	$1.14M	―	-1.29%	―	-18.88%	87.50%
CANN	37 Underperform	$4.44M	-1.24	―	―	―	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%